Foresite Capital Fund VI LP · beneficial owner of Latigo Biotherapeutics, Inc. · 4h agono track record yet
Long 9,181,328 shares of ALMS
9,181,328 shares · 14.5% of class · 2026-08-10
Schedule 13D: Foresite Capital Fund VI LP disclosed a stake in ALMS
Foresite Capital Fund VI LP disclosed a 14.5% stake of 9,181,328 shares in Latigo Biotherapeutics, Inc. (ALMS) in a Schedule 13D filed 2026-08-17.
Now $25.391m ago